Siemens, Gamma Medica end SPECT, SPECT-CT partnership

TriMed Staff | | Health Imaging | Diagnostic Imaging
Siemens Medical Solutions and Gamma Medica Inc. this week announced that they will not renew their worldwide marketing agreement which included exclusive marketing rights for Siemens to market Gamma Medica's pre-clinical SPECT and SPECT/CT imaging products, according to a joint release.
   
Gamma Medica CEO Bradley Patt, PhD, indicated that though the market is expanding rapidly, the company's agreement had to be ended because of Siemens' impending purchase of CTI and also because of the existing overlap between the two companies' pre-clinical products, the companies said.

TriMed Staff

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.